Abivax ABVX
NASDAQ ABVX
$93.49 +0.90 (+0.97%)
At close: Oct 21, 2026 · 4:00 PM EDT

Abivax (ABVX) Other Non-Current Liabilities (2021 - 2026)

Updated

Abivax (ABVX) reported Other Non-Current Liabilities of $4.12 million for Q2 2025, up 79.1% from $2.3 million a year earlier and up 3.2% from the prior quarter.

Analysis

Abivax (ABVX) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2024, Abivax posted Other Non-Current Liabilities of $3.92 million.

  • Other Non-Current Liabilities has a three-year compound annual growth rate of -30.7% (FY2021 to FY2024).
  • By year, Other Non-Current Liabilities came in at $596,539 in FY2022 (-94.9%) and $11.75 million in FY2021.
  • The Q2 2025 figure ranks as the highest quarterly Other Non-Current Liabilities since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Abivax 6.50 Bn 4.14 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 25.44 Mn
Dec 31, 2025 41.47 Mn
Jun 30, 2025 4.27 Mn
Mar 31, 2025 4.11 Mn
Dec 31, 2024 3.77 Mn
Jun 30, 2024 6.70 Mn
Mar 31, 2024 5.88 Mn
Dec 31, 2022 603,398.63
Dec 31, 2021 11.25 Mn
API Access

Abivax Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ABVX&period=max&api_key=YOUR_API_KEY